Description
A COX inhibitor (IC50s = 15.3 and 20.4 nM for the recombinant human COX-1 and COX-2, respectively) and the active metabolite of nepafenac; reduces the migration of 92.1 uveal melanoma cells at 150 nM, as well as proliferation of the same cells when used in combination with ranibizumab
Formal name: 2-amino-3-benzoyl-benzeneacetic acid, monosodium salt, monohydrate
Synonyms:
Molecular weight: 295.3
CAS: 61618-27-7
Purity: ≥98%
Formulation: A crystalline solid